Medical/Pharmaceuticals

Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting Balloon

NYON, Switzerland, Oct. 12, 2020 /PRNewswire/ -- MedAlliance has announced enrolment of the first two patients in the PRISTINE registry with SELUTION SLR™ 018 DEB for the treatment of patients with Below The Knee disease (Chronic Limb Threatening Ischemia). This is the first DEB accepted by the F...

2020-10-12 13:56 4532

Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42,an FXR Agonist

SHANGHAI, Oct. 12, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) announces today that it received investigational new drug application (IND) approval from FDA for its drug candidate ASC42, to conduct clinical trials for non-alcoholic ste...

2020-10-12 08:30 8672

CStone Announces Completion of $200 million Share Sale to Pfizer

SUZHOU, China, Oct. 12, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) announced today the completion of the Share Subscription Agreement through which an affiliate of Pfizer Inc. ("Pfizer", NYSE: PFE) subscribed for newly issued CStone shares at approximatelyUS$200 million (e...

2020-10-12 08:05 6160

Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA® (Rituximab Injection) in China

SAN FRANCISCO and SUZHOU, China, Oct. 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...

2020-10-09 19:14 11738

Frost & Sullivan Presents 5 Key Technologies and Investments in Mental Health Management

In observance of World Mental Health Day 2020, healthcare experts share key findings on investments and tools contributing to treatments for mental health disorders SANTA CLARA, Calif., Oct. 9, 2020 /PRNewswire/ -- Isolation and loneliness due to the COVID-19 pandemic have caused stress, anxiety...

2020-10-09 15:02 3341

TropIQ Health Sciences Digitalises Its Discovery Platform with CDD Vault

CDD Vault will enable TropIQ Health Sciences to share research results with partners in real time NIJMEGEN, Netherlands and SAN FRANCISCO, Oct. 9, 2020 /PRNewswire/ -- TropIQ Health Sciences, a  biotechnology social enterprise with a dual purpose to provide enabling technologies and expertise in...

2020-10-09 12:00 2631

CBC-incubated Everest Medicines Successfully Lists on HKEX

SHANGHAI, Oct. 9, 2020 /PRNewswire/ -- CBC Group ("CBC"), a healthcare-dedicated investment platform, today celebrates the initial public offering (IPO) of Everest Medicines ("Everest") (1952.HK), a portfolio company incubated by CBC, on the Stock Exchange ofHong Kong. Everest Medicines is a l...

2020-10-09 09:31 11810

HelpMeSee Launches Revolutionary Technology in Response to the Global Cataract Crisis

Not-for-profit campaign announces medical training breakthrough with its Eye Surgery Simulator NEW YORK, Oct. 9, 2020 /PRNewswire/ -- HelpMeSee, the not-for-profit global campaign to end cataract blindness, today announced a landmark achievement in medical simulation training with the completion ...

2020-10-09 09:00 4230

Ascentage Pharma's Apoptosis-Targeting Drug Candidates Granted Two More Orphan Drug Designations by the US FDA

SUZHOU, China and ROCKVILLE, MD., Oct. 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Adm...

2020-10-09 08:21 3050

Mentice to Acquire Eqip and MyIRlog™

STOCKHOLM, Oct. 9, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC) today signed an agreement to acquire all assets of the Jacksonville, Florida based MedTech company Eqip, Inc., a health IT cloud services and data analytics startup.   Eqip's flagship solution, MyIRlog™, is currently being used by clo...

2020-10-09 05:26 3551

Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate

Agreement provides option for European Union Member States to secure up to 200 million additional doses for a total of up to 400 million doses NEW BRUNSWICK, N.J., Oct. 8, 2020 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on beh...

2020-10-08 23:22 10000

Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant

- Membrane manufacturing facility for aseptic filters will help meet customer demand in the growing biopharmaceutical market - Investment of more than € 140 million creates approximately 55 new jobs - Construction expected to be completed in 2022 DARMSTADT, Germany, Oct. 8, 2020 /PRNewswire/ --...

2020-10-08 20:30 4454

Life-changing medical innovations that makes the impossible possible

STOCKHOLM, Oct. 8, 2020 /PRNewswire/ -- Medical wire that stops the trembling caused by Parkinson's disease. Precision tools that can manufacture tailored prosthetic limbs durable and flexible enough to race down the slopes. And 3D-printing technologies that can create scull and spinal implants i...

2020-10-08 19:45 10765

ITRI's Tech Innovation for COVID-19 Featured on Discovery Channel

TAIPEI, Oct. 8, 2020 /PRNewswire/ -- "Taiwan Revealed", a TV documentary series produced by Discovery Channel, premiered today inTaipei, highlighting Taiwan's technological innovations including the iPMx Molecular Rapid Test System developed byIndustrial Technology Research Institute(ITRI) <...

2020-10-08 17:17 5387

Patia and Precision Diabetes, Inc. Announce Strategic Alliance to Commercialize Precision Diagnostics for Diabetes

SAN SEBASTIAN, Spain and RALEIGH, North Carolina, Oct. 7, 2020 /PRNewswire/ -- Patia Biopharma, SA, and Precision Diabetes, Inc. are pleased to announce they have entered into a global strategic alliance to transform the diagnostic assessment of diabetes by providing a portfolio of novel precisio...

2020-10-07 19:00 2711

JHBP (CY) Holdings Limited (6998.HK) Successfully listed on the Main Board of SEHK

HONG KONG, Oct. 7, 2020 /PRNewswire/ -- JHBP (CY) Holdings Limited ("Genor Biopharma"or the "Company"; stock code: 6998.HK), a commercial-ready biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs, was successfully listed and commenced trading on the ...

2020-10-07 18:05 8159

Frost & Sullivan Recognizes Allscripts as a Growth and Innovation Leader in the United States Healthcare Data Interoperability Market

Allscripts enables enterprise-level, interoperability-aided EMR workflow adjustments and the subsequent clinical decision-making from a single window SANTA CLARA, Calif., Oct. 7, 2020 /PRNewswire/ -- Frost & Sullivan has identified Allscripts, a global healthcare IT company, as a growth and inno...

2020-10-07 18:02 3565

Dr Ivan Puah Designs Tailored Surgical Technique To Address Bodybuilders' Prominent Breast Deformity Issue

SINGAPORE, Oct. 7, 2020 /PRNewswire/ -- The use of anabolic steroid is a common practice in the preoccupation for a muscled physique particularly among male bodybuilders. Among those who engage in such practices, some have developed breast deformity called gynecomastia or enlarged male breasts...

2020-10-07 16:11 3504

Innovent Announces the Effectiveness of the Expanded Global Collaboration with Lilly on TYVYT® (sintilimab injection) Following the Expiration of HSR Act Waiting Period

SAN FRANCISCO and SUZHOU, China, Oct. 7, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major dis...

2020-10-07 08:00 14400

First Commercial Drug Manufactured via Ajinomoto Bio-Pharma Services' AJIPHASE Technology Receives FDA Approval

TOKYO, Oct. 6, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that the US FDA has approved the first commercial drug manufactured via Aji Bio-Pharma's proprietar...

2020-10-06 22:20 3304
1 ... 336337338339340341342 ... 396

Week's Top Stories